Phesi Global Analysis of 2.5 Million Patients Finds Participants in Breast Cancer Clinical Trials Are Getting Younger
New analysis from Phesi Inc. has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased dramatically, with an overall increase in trial participants younger than 60 years of age from 30% to about 80%. The results emerge following a global analysis of 2,511,046 breast cancer patients from 4,674 investigator sites.
Read more about the analysis from Phesi here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
